Targeted genome editing in acute lymphoblastic leukemia: a review

Targeted genome editing in acute lymphoblastic leukemia: a review

Abstract Background Genome editing technologies offers new opportunities for tackling diseases such as acute lymphoblastic leukemia (ALL) that have been beyond the reach of previous therapies. Results We show how the recent availability of genome-editing tools such as CRISPR-Cas9 are an important me...

Full description

Bibliographic Details
Main Authors: Adrián Montaño, Maribel Forero-Castro, Jesús-María Hernández-Rivas, Ignacio García-Tuñón, Rocío Benito
Format: Article
Language:English
Published: BMC 2018-07-01
Series:BMC Biotechnology
Subjects:
Acute lymphoblastic leukemia
CRISPR-Cas9
Genome editing
Online Access:http://link.springer.com/article/10.1186/s12896-018-0455-9

Similar Items

Similar Items